CV Sciences, Inc. engages in the development, manufacture, and sale of herbal supplements, CBD products and plant-based food products. The company is headquartered in San Diego, California and currently employs 42 full-time employees. The company went IPO on 2018-10-04. The firm develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under +PlusCBD, +PlusHLTH, Cultured Foods, and Lunar Fox brands in the healthcare market sector, including nutraceutical, beauty care, specialty foods, and pet products. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business (B2B) to business-to-consumer (B2C). Its +PlusCBD line of products are available in softgels, tinctures, topicals, and gummies. Its Cultured Foods and Lunar Fox cater to individuals seeking vegan, gluten-free, or flexitarian options for a nutritious and satisfying culinary experience. Its +PlusHLTH is a line of cannabinoid-free supplements delivering targeted formulations for optimized health, improved performance and increased vitality.
Mr. Joseph Dowling es el Chief Executive Officer de CV Sciences Inc, se unió a la empresa desde 2014.
¿Qué tal es el rendimiento del precio de la acción CVSI?
El precio actual de CVSI es de $0, ha disminuido un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de CV Sciences Inc?
CV Sciences Inc pertenece a la industria Consumer products y el sector es Consumer Staples
¿Cuál es la capitalización bursátil de CV Sciences Inc?
La capitalización bursátil actual de CV Sciences Inc es $NaN
¿Es CV Sciences Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para CV Sciences Inc, incluyendo 0 fuerte compra, 0 compra, 3 mantener, 1 venta, y 0 fuerte venta